• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

    4/22/26 7:15:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials
    Get the next $DHR alert in real time by email

    WASHINGTON, April 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"):

    • €500,000,000 principal amount of floating rate senior notes due 2028 at an offering price of 100.000% of the principal amount;



    • €750,000,000 principal amount of 3.250% senior notes due 2030 at an offering price of 99.934% of the principal amount;



    • €750,000,000 principal amount of 3.625% senior notes due 2034 at an offering price of 99.918% of the principal amount; and



    • €1,000,000,000 principal amount of 4.000% senior notes due 2038 at an offering price of 99.953% of the principal amount (collectively, the "senior notes").

    Danaher estimates that the net proceeds from the sale of the senior notes will be approximately €2.98 billion, after deducting the underwriting discounts and estimated offering expenses payable by Danaher. Danaher intends to use the net proceeds from the sale of the senior notes to pay a portion of the cash consideration payable for, and certain costs associated with, its acquisition of Masimo Corporation. Danaher may also use a portion of the net proceeds from the sale of the senior notes for general corporate purposes, which may include, without limitation and in Danaher's sole discretion, refinancing of outstanding indebtedness, working capital, capital expenditures and satisfaction of other obligations. The Offering is expected to close on April 29, 2026, subject to the satisfaction of customary closing conditions.

    The Offering is being made pursuant to an effective shelf registration statement on Form S-3ASR (File No. 333-278426) filed by Danaher with the U.S. Securities and Exchange Commission on April 1, 2024, and only by means of a prospectus and prospectus supplement. A preliminary prospectus supplement and an issuer free writing prospectus have been filed, and a prospectus supplement relating to the Offering will be filed, with the SEC, to which this communication relates. Prospective investors should read the issuer free writing prospectus, preliminary prospectus supplement and accompanying prospectus forming a part of that registration statement and the other documents that Danaher has filed with the SEC for more complete information about Danaher and the Offering. These documents are available at no charge by visiting EDGAR on the SEC website at www.sec.gov. A copy of the prospectus and prospectus supplement relating to the securities can also be obtained by calling Citigroup Global Markets Limited at +1-800-831-9146; Merrill Lynch International at +1-800-294-1322; Barclays Bank PLC at +1-888-603-5847; Deutsche Bank AG, London Branch at +1-800-503-4611; and Goldman Sachs & Co. LLC at +1-866-471-2526.

    This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, the senior notes or any other securities, nor shall there be any offer, solicitation or sale of any security mentioned in this press release in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    The senior notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area ("EEA"). For these purposes, a retail investor means a person who is one (or more) of the following: (i) a "retail client" as defined in point (11) of Article 4(1) of Directive (EU) 2014/65 (as amended, "MiFID II") or (ii) a customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs Regulation") for offering or selling the senior notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the senior notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation.

    The senior notes are not intended to be offered, sold, distributed or otherwise made available to and should not be offered, sold, distributed or otherwise made available to any retail investor in the UK. For these purposes, a retail investor means a person who is not a professional client as defined in Article 2(1)(8) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. Consequently no disclosure document required by the FCA Product Disclosure Sourcebook ("DISC") for offering, selling, or distributing the senior notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering, selling or distributing the senior notes or otherwise making them available to any retail investor in the UK may be unlawful under DISC and the Consumer Composite Investments (Designated Activities) Regulations 2024.

    This communication is being distributed only to, and is directed at persons who (i) persons who are outside the UK, (ii) persons who have professional experience in matters relating to investments and are investment professionals as defined within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Order"), (iii) high net worth bodies corporate and any other person falling within Article 49(2)(a) to (d) of the Order, or (iv) persons to whom an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000 in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). This announcement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

    ABOUT DANAHER

    Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 60,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow.

    FORWARD-LOOKING STATEMENTS

    Statements in this release that are not strictly historical, including the statements regarding the timing and completion of the Offering, the anticipated use of proceeds therefrom and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be "forward-looking statements" within the meaning of the federal securities laws. There are a number of important factors that could cause actual events, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in Danaher's SEC filings, including Danaher's 2025 Annual Report on Form 10-K and Danaher's Quarterly Report on Form 10-Q for the first quarter of 2026. These forward-looking statements speak only as of the date of this release and, except to the extent required by applicable law, Danaher does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

    Cision View original content:https://www.prnewswire.com/news-releases/danaher-announces-pricing-of-euro-denominated-senior-notes-offering-302750942.html

    SOURCE Danaher Corporation

    Get the next $DHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHR

    DatePrice TargetRatingAnalyst
    6/11/2026$200.00Neutral
    Piper Sandler
    6/3/2026$210.00Buy
    DZ Bank
    6/2/2026Peer Perform
    Wolfe Research
    5/26/2026$230.00Buy
    Citigroup
    5/15/2026$200.00Outperform
    RBC Capital Mkts
    12/9/2025$265.00Buy
    Goldman
    12/2/2025$270.00Overweight
    Morgan Stanley
    10/8/2025$220.00Buy → Neutral
    Rothschild & Co Redburn
    More analyst ratings

    $DHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Human Resources Couchara Georgeann covered exercise/tax liability with 281 shares, decreasing direct ownership by 3% to 8,291 units (SEC Form 4)

    4 - DANAHER CORP /DE/ (0000313616) (Issuer)

    5/19/26 5:10:04 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Director Filler Linda was granted 680 shares, increasing direct ownership by 3% to 24,712 units (SEC Form 4)

    4 - DANAHER CORP /DE/ (0000313616) (Issuer)

    5/19/26 5:10:11 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Director Stevens Raymond C was granted 680 shares, increasing direct ownership by 5% to 13,728 units (SEC Form 4)

    4 - DANAHER CORP /DE/ (0000313616) (Issuer)

    5/19/26 5:09:58 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on Danaher with a new price target

    Piper Sandler initiated coverage of Danaher with a rating of Neutral and set a new price target of $200.00

    6/11/26 8:10:54 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    DZ Bank initiated coverage on Danaher with a new price target

    DZ Bank initiated coverage of Danaher with a rating of Buy and set a new price target of $210.00

    6/3/26 8:10:49 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Wolfe Research resumed coverage on Danaher

    Wolfe Research resumed coverage of Danaher with a rating of Peer Perform

    6/2/26 8:32:53 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    SEC Filings

    View All

    SEC Form 11-K filed by Danaher Corporation

    11-K - DANAHER CORP /DE/ (0000313616) (Filer)

    6/16/26 5:09:15 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SEC Form S-8 filed by Danaher Corporation

    S-8 - DANAHER CORP /DE/ (0000313616) (Filer)

    6/8/26 9:48:27 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Danaher Corporation filed SEC Form 8-K: Other Events

    8-K - DANAHER CORP /DE/ (0000313616) (Filer)

    6/3/26 4:30:18 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Danaher Schedules Second Quarter 2026 Earnings Conference Call

    WASHINGTON, June 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2026 on Tuesday, July 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.You can

    6/22/26 4:15:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner

    Powered by smartSET™, the Pattern Recognition Capability Analyzes Continuous Patient Data to Provide Clinicians With Earlier Insight Into Opioid-Related Respiratory Risk Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring solutions, today announced FDA 510(k) clearance for an opioid-induced respiratory depression detection capability integrated into the Radius VSM® wearable continuous patient monitor. Enabled by Masimo’s next-generation smartSET™ pulse oximetry sensor platform, the new feature uses advanced pattern recognition that analyzes continuous physiologic data to help clinicians identify early signs of respirator

    6/22/26 8:00:00 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Danaher Completes Acquisition of Masimo Corporation

    WASHINGTON, June 10, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care treatment settings. Masimo's trusted brand, advanced sensor technology and AI-enabled patient monitoring bring complementary and powerful new capabilities to the Danaher diagnostics portfolio. As a result of the transaction, Masimo is now a wholly-owned subsidiary of Danaher and Masimo common stock has ceased trading on the Nasdaq Stock Market. Masimo will continue to operate unde

    6/10/26 8:55:00 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Financials

    Live finance-specific insights

    View All

    Danaher Schedules Second Quarter 2026 Earnings Conference Call

    WASHINGTON, June 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2026 on Tuesday, July 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.You can

    6/22/26 4:15:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Danaher Completes Acquisition of Masimo Corporation

    WASHINGTON, June 10, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care treatment settings. Masimo's trusted brand, advanced sensor technology and AI-enabled patient monitoring bring complementary and powerful new capabilities to the Danaher diagnostics portfolio. As a result of the transaction, Masimo is now a wholly-owned subsidiary of Danaher and Masimo common stock has ceased trading on the Nasdaq Stock Market. Masimo will continue to operate unde

    6/10/26 8:55:00 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Danaher Announces Quarterly Dividend

    WASHINGTON, May 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 31, 2026 to holders of record on June 26, 2026. ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve many of their most complex scientific and clinical challenges—helping move innovations from discovery to delivery faster for patients who depend on them.Pow

    5/5/26 4:30:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Leadership Updates

    Live Leadership Updates

    View All

    Sirius XM Holdings Set to Join S&P MidCap 400

    NEW YORK, June 8, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASD: SIRI) will replace Masimo Corp. (NASD: MASI) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, June 11. S&P 500 & 100 constituent Danaher Corp. (NYSE:DHR) is acquiring Masimo in a deal expected to be completed soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective Date Index Name Action Company Name Ticker GICS Sector  June 11, 2026  S&P MidCap 400 Addition Sirius XM HoldingsSIRI Communication Services  June 11, 2026  S&P MidCap 400 Deletion MasimoMASI Health Care ABOUT S&P DOW JONES INDICESS&P Dow Jon

    6/8/26 6:09:00 PM ET
    $DHR
    $MASI
    $SIRI
    Industrial Machinery/Components
    Industrials
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Danaher To Acquire Masimo Corporation

    WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ:MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $9.9 billion including assumed indebtedness and net of acquired cash. This represents a transaction multiple of approximately 18x estimated 2027 EBITDA, or 15x 2

    2/17/26 8:00:00 AM ET
    $DHR
    $MASI
    Industrial Machinery/Components
    Industrials
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    AstroNova Appoints Jorik E. Ittmann as President and Chief Executive Officer

    Leverages Mr. Ittmann's extensive print industry and international business experience Padraig Finn, with over 16 years in the print industry, promoted to Senior Vice President, Product Identification Tom Carll, Senior Vice President, Aerospace, Thomas DeByle, CFO, and Michael Natalizia, Chief Technology Officer, round out the Executive Leadership Team Darius G. Nevin appointed Executive Chairman AstroNova, Inc. (NASDAQ:ALOT), a leading innovator in specialized print technology solutions that enable data visualization, today announced that the Board of Directors has promoted Jorik E. Ittmann to President and CEO and appointed him to the Board of Directors, both to be effective

    8/4/25 9:00:00 AM ET
    $ALOT
    $DHR
    $VLTO
    Computer peripheral equipment
    Technology
    Industrial Machinery/Components
    Industrials

    $DHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Danaher Corporation (Amendment)

    SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)

    2/9/23 11:16:32 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Danaher Corporation (Amendment)

    SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)

    2/9/22 3:43:35 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13D/A filed by Danaher Corporation (Amendment)

    SC 13D/A - DANAHER CORP /DE/ (0000313616) (Subject)

    11/2/21 9:29:29 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials